A new pathway for primary aldosteronism treatment

Affiliations

¹ Calgary Adrenal Research Group, University of Calgary, Calgary, AB T2T 5C7, Canada.
² Calgary Adrenal Research Group, University of Calgary, Calgary, AB T2T 5C7, Canada. Electronic address: Gregory.kline@ahs.ca.

Comment

Alexander A Leung et al. Lancet. 2025.

. 2025 Feb 22;405(10479):599-601.

doi: 10.1016/S0140-6736(25)00051-0. Epub 2025 Feb 7.

¹ Calgary Adrenal Research Group, University of Calgary, Calgary, AB T2T 5C7, Canada.
² Calgary Adrenal Research Group, University of Calgary, Calgary, AB T2T 5C7, Canada. Electronic address: Gregory.kline@ahs.ca.

No abstract available

Conflict of interest statement

We declare no competing interests.

Endoscopic, ultrasound-guided, radiofrequency ablation of aldosterone-producing adenomas (FABULAS): a UK, multicentre, prospective, proof-of-concept trial.
Argentesi G, Wu X, Ney A, Goodchild E, Laycock K, Lee YN, Senanayake R, MacFarlane J, Ng E, Kearney J, O'Toole S, Salsbury J, Carroll N, Gillett D, Tadross JA, Marker A, Godfrey EM, Goodchild G, Bestwick JP, Gurnell M, Cheow H, Pereira SP, Drake WM, Brown MJ; FABULAS study group. Argentesi G, et al. Lancet. 2025 Feb 22;405(10479):637-647. doi: 10.1016/S0140-6736(24)02755-7. Epub 2025 Feb 7. Lancet. 2025. PMID: 39929216